TRIB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Trinity Biotech plc

NASDAQ | TRIB

1.62

USD

0.00

(

0.00%

)

AT CLOSE (AS OF Aug 15, 2025)

$36M

MARKET CAP

-

P/E Ratio

-1.8

EPS

$3.4

52 Week High

$0.48

52 Week Low

LIFE SCIENCES

Sector

TRIB Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn more about backtests Upgrade Now
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn more about scanner Upgrade Now

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn more about signals Upgrade Now
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

Learn more about journal Upgrade Now
Upgrade Now

TRIB Technicals

Tags:

TRIB News

TRIB Profile

Trinity Biotech plc Profile

Sector: LIFE SCIENCES

Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.